Sfoglia per Autore
Role of galectin-3 immunodetection in the cytological diagnosis of thyroid cystic papillary carcinoma.
2002-01-01 PAPOTTI M ;VOLANTE M ;SAGGIORATO E ;DEANDREIS D ;VELTRI A ;ORLANDI F.
Acromegaly due to ectopic secretion of GHRH by bronchial carcinoid in a patient with empty sella
2003-01-01 G. OSELLA; F. ORLANDI; P. CARACI; M. VENTURA; D. DEANDREIS; M. PAPOTTI; M. BONGIOVANNI; A. ANGELI; M. TERZOLO
Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas
2004-01-01 Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
Thyroid volume and urinary iodine excretion in the schoolchild population of a Northwestern Italian sub-Alp metropolitan area
2004-01-01 Saggiorato E; Mussa A; Sacerdote C; Rossetto R; Arecco F; Origlia C; Germano L; Deandreis D; Orlandi F; Piemonte Goiter Study Committee
Goiter prevalence and urinary iodine status in urban and rural/mountain areas of Piedmont region
2006-01-01 SAGGIORATO E; ARECCO F; MUSSA A; SACERDOTE C; ROSSETTO R; ORIGLIA C; GERMANO L; DEANDREIS D; ORLANDI F; PIEDMONT GOITER STUDY COMMITTEE
Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site
2006-01-01 PELOSI E; PENNONE M; DEANDREIS D; DOUROUKAS A; MANCINI M; BISI G
FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
2008-01-01 Pelosi E; Penna D; Deandreis D; Chiappella A; Skanjeti A; Vitolo U; Bisi G.
Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma.
2008-01-01 Pelosi E; Pregno P; Penna D; Deandreis D; Chiappella A; Limerutti G; Vitolo U; Mancini M; Bisi G; Gallo E.
Dual-phase F-18 FDG PET/CT scanning in the suspicion of relapse of ovarian neoplasia.
2009-01-01 Penna D; Varetto T; Deandreis D; Castellano G; Bisi G.
Adrenocortical carcinoma: Is the surgical approach a risk factor of peritoneal carcinomatosis?
2010-01-01 Leboulleux S.; Deandreis D.; Al Ghuzlan A.; Auperin A.; Goere D.; Dromain C.; Elias D.; Caillou B.; Travagli J.P.; De Baere T.; Lumbroso J.; Young J.; Schlumberger M.; Baudin E.
Performance of 18fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (≥10%) well-differentiated endocrine carcinoma staging
2011-01-01 Abgral R.; Leboulleux S.; Deandreis D.; Auperin A.; Lumbroso J.; Dromain C.; Duvillard P.; Elias D.; De Baere T.; Guigay J.; Ducreux M.; Schlumberger M.; Baudin E.
Fluorodesoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: Do not consider it as malignancy
2011-01-01 Leboulleux S.; Deandreis D.; Escourrou C.; Al Ghuzlan A.; Bidault F.; Auperin A.; Travagli J.P.; Lumbroso J.; Schlumberger M.; Baudin E.
Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation.
2011-01-01 Deandreis, Désirée; Leboulleux, S; Dromain, C; Auperin, A; Coulot, J; Lumbroso, J; Deschamps, F; Rao, P; Schlumberger, M; de Baère, T.
Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?
2011-01-01 Deandreis, D.*; Al Ghuzlan, A.; Leboulleux, S.; Lacroix, L.; Garsi, J.P.; Talbot, M.; Lumbroso, J.; Baudin, E.; Caillou, B.; Bidart, J.M.; Schlumberger, M.
FDG PET in the management of patients with adrenal masses and Adrenocortical carcinoma
2011-01-01 Deandreis D.; Leboulleux S.; Caramella C.; Schlumberger M.; Baudin E.
Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology?
2012-01-01 Deandreis, Désirée; Al Ghuzlan, A; Auperin, A; Vielh, P; Caillou, B; Chami, L; Lumbroso, J; Travagli, Jp; Hartl, D; Baudin, E; Schlumberger, M; Leboulleux, S.
Strategies of radioiodine ablation in patients with low-risk thyroid cancer
2012-01-01 Schlumberger, M; Catargi, B; Borget, I; Deandreis, Désirée; Zerdoud, S; Bridji, B; Bardet, S; Leenhardt, L; Bastie, D; Schvartz, C; Vera, P; Morel, O; Benisvy, D; Bournaud, C; Bonichon, F; Dejax, C; Toubert, Me; Leboulleux, S; Ricard, M; Benhamou, E; Tumeurs de la Thyroïde Refractaires Network for the Essai Stimulation Ablation Equivalence Trial,
Pelosi E, Deandreis D (2012). FDG PET and Colorectal Cancer. In: Strauss HW, MAriani G, Volterrani D, Larson SM. Nuclear Oncology. Pathophysiology and Clinical Applications.
2012-01-01 Pelosi E, Deandreis D
Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging
2013-01-01 Gouy, Sebastien; Morice, Philippe; Narducci, Fabrice; Uzan, Catherine; Martinez, Alejandra; Rey, Annie; Bentivegna, Enrica; Pautier, Patricia; Deandreis, Desiree; Querleu, Denis; Haie-Meder, Christine; Leblanc, Eric
Caractérisation des tumeurs neuroendocrines digestives ou thoraciques
2013-01-01 Baudin, E.; Scoazec, J. -Y.; Caramella, C.; Leboulleux, S.; Caron, O.; Deandreis, D.; Duvillard, P.; Lumbroso, J.; Baere, T. de; Deschamps, F.; Goere, D.; Dumont, F.; Elias, D.; Malka, D.; Boige, V.; Schlumberger, M.; Guigay, J.; Planchard, D.; Ducreux, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Role of galectin-3 immunodetection in the cytological diagnosis of thyroid cystic papillary carcinoma. | 2002 | PAPOTTI M ;VOLANTE M ;SAGGIORATO E ;DEANDREIS D ;VELTRI A ;ORLANDI F. | |
| Acromegaly due to ectopic secretion of GHRH by bronchial carcinoid in a patient with empty sella | 2003 | G. OSELLA; F. ORLANDI; P. CARACI; M. VENTURA; D. DEANDREIS; M. PAPOTTI; M. BONGIOVANNI; A. ANGELI; M. TERZOLO | |
| Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas | 2004 | Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F | |
| Thyroid volume and urinary iodine excretion in the schoolchild population of a Northwestern Italian sub-Alp metropolitan area | 2004 | Saggiorato E; Mussa A; Sacerdote C; Rossetto R; Arecco F; Origlia C; Germano L; Deandreis D; Orlandi F; Piemonte Goiter Study Committee | |
| Goiter prevalence and urinary iodine status in urban and rural/mountain areas of Piedmont region | 2006 | SAGGIORATO E; ARECCO F; MUSSA A; SACERDOTE C; ROSSETTO R; ORIGLIA C; GERMANO L; DEANDREIS D; ORLANDI F; PIEDMONT GOITER STUDY COMMITTEE | |
| Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site | 2006 | PELOSI E; PENNONE M; DEANDREIS D; DOUROUKAS A; MANCINI M; BISI G | |
| FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management. | 2008 | Pelosi E; Penna D; Deandreis D; Chiappella A; Skanjeti A; Vitolo U; Bisi G. | |
| Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma. | 2008 | Pelosi E; Pregno P; Penna D; Deandreis D; Chiappella A; Limerutti G; Vitolo U; Mancini M; Bisi G; Gallo E. | |
| Dual-phase F-18 FDG PET/CT scanning in the suspicion of relapse of ovarian neoplasia. | 2009 | Penna D; Varetto T; Deandreis D; Castellano G; Bisi G. | |
| Adrenocortical carcinoma: Is the surgical approach a risk factor of peritoneal carcinomatosis? | 2010 | Leboulleux S.; Deandreis D.; Al Ghuzlan A.; Auperin A.; Goere D.; Dromain C.; Elias D.; Caillou B.; Travagli J.P.; De Baere T.; Lumbroso J.; Young J.; Schlumberger M.; Baudin E. | |
| Performance of 18fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (≥10%) well-differentiated endocrine carcinoma staging | 2011 | Abgral R.; Leboulleux S.; Deandreis D.; Auperin A.; Lumbroso J.; Dromain C.; Duvillard P.; Elias D.; De Baere T.; Guigay J.; Ducreux M.; Schlumberger M.; Baudin E. | |
| Fluorodesoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: Do not consider it as malignancy | 2011 | Leboulleux S.; Deandreis D.; Escourrou C.; Al Ghuzlan A.; Bidault F.; Auperin A.; Travagli J.P.; Lumbroso J.; Schlumberger M.; Baudin E. | |
| Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation. | 2011 | Deandreis, Désirée; Leboulleux, S; Dromain, C; Auperin, A; Coulot, J; Lumbroso, J; Deschamps, F; Rao, P; Schlumberger, M; de Baère, T. | |
| Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome? | 2011 | Deandreis, D.*; Al Ghuzlan, A.; Leboulleux, S.; Lacroix, L.; Garsi, J.P.; Talbot, M.; Lumbroso, J.; Baudin, E.; Caillou, B.; Bidart, J.M.; Schlumberger, M. | |
| FDG PET in the management of patients with adrenal masses and Adrenocortical carcinoma | 2011 | Deandreis D.; Leboulleux S.; Caramella C.; Schlumberger M.; Baudin E. | |
| Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology? | 2012 | Deandreis, Désirée; Al Ghuzlan, A; Auperin, A; Vielh, P; Caillou, B; Chami, L; Lumbroso, J; Travagli, Jp; Hartl, D; Baudin, E; Schlumberger, M; Leboulleux, S. | |
| Strategies of radioiodine ablation in patients with low-risk thyroid cancer | 2012 | Schlumberger, M; Catargi, B; Borget, I; Deandreis, Désirée; Zerdoud, S; Bridji, B; Bardet, S; Leenhardt, L; Bastie, D; Schvartz, C; Vera, P; Morel, O; Benisvy, D; Bournaud, C; Bonichon, F; Dejax, C; Toubert, Me; Leboulleux, S; Ricard, M; Benhamou, E; Tumeurs de la Thyroïde Refractaires Network for the Essai Stimulation Ablation Equivalence Trial, | |
| Pelosi E, Deandreis D (2012). FDG PET and Colorectal Cancer. In: Strauss HW, MAriani G, Volterrani D, Larson SM. Nuclear Oncology. Pathophysiology and Clinical Applications. | 2012 | Pelosi E, Deandreis D | |
| Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging | 2013 | Gouy, Sebastien; Morice, Philippe; Narducci, Fabrice; Uzan, Catherine; Martinez, Alejandra; Rey, Annie; Bentivegna, Enrica; Pautier, Patricia; Deandreis, Desiree; Querleu, Denis; Haie-Meder, Christine; Leblanc, Eric | |
| Caractérisation des tumeurs neuroendocrines digestives ou thoraciques | 2013 | Baudin, E.; Scoazec, J. -Y.; Caramella, C.; Leboulleux, S.; Caron, O.; Deandreis, D.; Duvillard, P.; Lumbroso, J.; Baere, T. de; Deschamps, F.; Goere, D.; Dumont, F.; Elias, D.; Malka, D.; Boige, V.; Schlumberger, M.; Guigay, J.; Planchard, D.; Ducreux, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile